Hepatosplenic gamma-delta T-cell lymphoma (HSTCL) is a rare, aggressive subset of peripheral T-cell lymphoma. It has been reported that Epstein-Barr virus (EBV) infection can cause HSTCL; however, such cases are extremely rare, with only a few cases having been reported to date. We herein report an autopsy case of HSTCL associated with EBV infection. The presence of EBV infection was confirmed in serum EBV DNA and on in-situ hybridization, and cytotoxic molecules, such as granzyme B, perforin and T-cell intracytoplasmic antigen (TIA)-1, were all positive in lymphoma cells. These findings indicate that stimulation of persistent EBV infection may have caused HSTCL in this patient.
Introduction
Hepatosplenic gamma-delta T-cell lymphoma (HSTCL) is a rare extranodal T-cell non-Hodgkin's lymphoma characterized by hepatosplenomegaly without lymphadenopathy (1) . Most HSTCL lesions are found in patients with autoimmune disease, chronic antigen stimulation, splenectomy and/or under immunosuppressive treatment, mostly after solid organ transplantation (2) . HSTCL usually shows the phenotype of CD2+, CD3+, CD4-, CD5-, CD7+, CD8-, T cell receptor (TCR) gamma-delta+ (3, 4) , while cytotoxic molecules, such as granzyme B and perforin, are usually negative in such lesions (3). Ohshima et al. reported a possible association between Epstein-Barr virus (EBV) infection and HSTCL; however, such HSTCL cases are extremely rare (5) . We herein report an autopsy case of HSTCL associated with chronic EBV infection.
Case Report
A 71-year-old man was diagnosed with bronchiolitis obliterans organizing pneumonia (BOOP) five months prior to onset. He was treated with a corticosteroid, and the BOOP gradually improved. The dose of the corticosteroid was started at 30 mg/day, then tapered to 7.5 mg/day; however, it was subsequently increased again to 15 mg/day because the BOOP worsened. The corticosteroid treatment was continued at a dose of 15 mg/day, and the BOOP remained well-controlled. However, five months after the diagnosis of BOOP, the patient developed a fever and was treated with antibiotics, although the fever did not resolve. He subsequently developed severe weakness and jaundice and was referred to our department after one month. On admission, blood tests showed pancytopenia, severe liver dysfunction with hyperbilirubinemia and renal dysfunction. The levels of soluble interleukin-2 receptor (sIL-2R) and serum lactate deDepartment of Gastroenterology and Hepatology, Hokkaido University, Graduate School of Medicine, Japan, Department of Surgical Pathology, Hokkaido University Hospital, Japan and Department of Pathology, Hokkaido University, Graduate School of Medicine, Japan hydrogenase (LDH) were also markedly elevated. Serological virus markers measured while the patient was alive were all negative (Table) . Ultrasound and computed tomography revealed massive hepatosplenomegaly that was not observed on the computed tomography scan performed four months before onset (Fig. 1) . No lymphadenopathy was detected. As a differential diagnosis, we considered hematological malignancies, including lymphoma, drug-induced liver dysfunction and viral infectious disease. A liver biopsy and bone marrow aspiration were planned to obtain a definitive diagnosis; however, the patient's clinical course was aggressive, and he died from multiple organ failure three days after admission.
Serological tests
An autopsy was subsequently performed, which showed the liver and spleen to be markedly enlarged, as observed earlier on ultrasound and computed tomography; their weights were 2,823 g and 814 g, respectively. No lymphadenopathy was observed. A microscopic examination revealed massive atypical lymphocyte infiltration into the liver, spleen and bone marrow. The infiltrated lymphocytes were positive for CD3 and T cell receptor (TCR)-γ and negative for CD4, CD5, CD8, CD20, CD56 and βF1 (Fig. 2, 3) . The presence of atypical cells positive for TCR-γ and negative for βF1 suggested the existence of TCR gamma-delta chains. These findings indicated the tumor cells to reflect T-cell lymphoma expressing TCR gamma-delta chains. Interestingly, in-situ hybridization for EBV and cytotoxic molecules, including granzyme B, perforin and T-cell intracytoplasmic antigen (TIA)-1 were all positive in the lymphoma cells (Fig. 2) , indicating a persistent infection of EBV with a cytotoxic reaction. The phenotypes of the lymphoma cells in the liver, spleen and bone marrow were exactly the same. Accordingly, we later measured the EBV DNA titer in the patient's stored serum, which revealed a high level of EBV DNA (Table) . The patient's condition was diagnosed as HSTCL associated with EBV infection.
Discussion
HSTCL is a rare subset of peripheral T-cell lymphoma that accounts for less than 1% of all non-Hodgkin's lymphomas (6). HSTCL has a peak incidence in adolescents and young adults. Patients with HSTCL commonly show hepatosplenomegaly in the absence of lymphadenopathy (1) . Pancytopenia is also a common feature of HSTCL due to bone marrow involvement (7) . The clinical course of HSTCL is aggressive, with a reported median survival time of eight months (3) . No effective combination chemotherapy has been documented to date, and the only curative treatment is allogeneic stem cell transplantation (8) . The patient in the present case report was relatively old; however, he exhibited the typical symptoms of HTSCL, including hepatosplenomegaly, thrombocytopenia, fever and weakness, and his clinical course was extremely aggressive.
HSTCL usually carries the phenotype of CD2+, CD3+, CD4-, CD5-, CD7+, CD8-, TCR gamma-delta+, and it is assumed that HTSCL may originate from gamma-delta TCRexpressing T-cells. Such T-cells demonstrate preferential homing to the sinusoidal areas of the liver, red pulp of the spleen and epithelial layer of the intestinal mucosa (9) . The lymphoma cells of HTSCL have similar characteristics and infiltrate into the sinusoidal areas of the liver, bone marrow and red pulp of the spleen without lymph node involvement. Most HSTCL cases express only TIA-1, not other cytotoxic molecules, such as granzyme B and perforin (10) . In contrast, non-hepatosplenic gamma-delta T-cell lymphomas, including nasal, cutaneous and intestinal gamma-delta T-cell lymphomas, often express all of cytotoxic molecules, and, interestingly, some are associated with EBV infection (11) . Although various lymphomas, including nasal natural killer (NK)/T-cell lymphomas, are caused by EBV infection (12) , only two cases of HTSCL associated with EBV have been reported thus far (5) . In both cases, all cytotoxic molecules (TIA-1, granzyme B and perforin) were expressed, and the patients died within one month. In the present case, we confirmed EBV infection on in-situ hybridization of the EBV region, and almost all of the lymphoma cells were positive. Furthermore, the lymphoma cells expressed all of the cytotoxic molecules, including TIA-1 and granzyme B, and the patient's clinical course was extremely aggressive. It is possible that EBV infection may either cause or accelerate HSTCL and activate cytotoxic molecules, leading to an extremely poor prognosis.
In conclusion, we herein reported an extremely rare case of HSTCL associated with EBV infection. The present case implies a possible association between HSTCL and EBV; however, the detailed mechanism by which EBV affects the onset of HSTCL remains to be elucidated. Further studies and the accumulation of cases of EBV-associated HSTCL are necessary.
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